These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36602290)

  • 21. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor.
    Becerril-Rico J; Alvarado-Ortiz E; Toledo-Guzmán ME; Pelayo R; Ortiz-Sánchez E
    Stem Cell Res Ther; 2021 Sep; 12(1):498. PubMed ID: 34503571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Stem Cells and Anti-tumor Immunity.
    Yılmaz M; Kaplan F; Mender I; Gryaznov SM; Dikmen ZG
    Curr Stem Cell Res Ther; 2023; 18(4):445-459. PubMed ID: 36263477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects.
    Li T; Liu T; Zhu W; Xie S; Zhao Z; Feng B; Guo H; Yang R
    Clin Med Insights Oncol; 2021; 15():11795549211035540. PubMed ID: 34408525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
    Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
    Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
    Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
    Front Immunol; 2020; 11():140. PubMed ID: 32117287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment.
    Xiong J; Wang H; Wang Q
    Adv Biol (Weinh); 2021 Mar; 5(3):e1900311. PubMed ID: 33729699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment.
    Zemek RM; De Jong E; Chin WL; Schuster IS; Fear VS; Casey TH; Forbes C; Dart SJ; Leslie C; Zaitouny A; Small M; Boon L; Forrest ARR; Muiri DO; Degli-Esposti MA; Millward MJ; Nowak AK; Lassmann T; Bosco A; Lake RA; Lesterhuis WJ
    Sci Transl Med; 2019 Jul; 11(501):. PubMed ID: 31316010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
    Shi H; Yang Y
    Cancer Med; 2021 Jun; 10(11):3794-3807. PubMed ID: 33932112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure.
    Castagnoli L; De Santis F; Volpari T; Vernieri C; Tagliabue E; Di Nicola M; Pupa SM
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.
    Luo S; Yang G; Ye P; Cao N; Chi X; Yang WH; Yan X
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer cells stemness: A doorstep to targeted therapy.
    Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition.
    Kim HJ; Cantor H; Cosmopoulos K
    Trends Immunol; 2020 Oct; 41(10):948-963. PubMed ID: 32976740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
    López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
    J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophages and cancer stem cells: a malevolent alliance.
    Allavena P; Digifico E; Belgiovine C
    Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Cancer Stem Cell Targeted Therapy.
    Akbulut H; Babahan C; Abgarmi SA; Ocal M; Besler M
    Crit Rev Oncog; 2019; 24(1):1-20. PubMed ID: 31679215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy.
    Guo W; Qiao T; Li T
    Semin Cancer Biol; 2022 Dec; 87():160-169. PubMed ID: 36371027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.